Basics XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. IPO Date: July 1, 1986 Sector: Healthcare Industry: Biotech Market Cap: $370.38M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.11% Avg Daily Range (30 D): $0.62 | 1.90% Avg Daily Range (90 D): $0.76 | 2.26% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 390 Avg Trade Size (Sh.) (30 D): 35 Avg Trade Size (Sh.) (90 D): 40 Institutional Trades Total Inst.Trades: 384 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $1.35M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.71M Avg Closing Trade (30 D): $1.35M Avg Closing Trade (90 D): $1.8M Avg Closing Volume: 77.56K     News Dec 5, 2025 @ 12:45 PM Mural Oncology Announces Effectiveness of Scheme o... Source: Globe Newswire Dec 3, 2025 @ 9:30 PM Mural Oncology Announces Sanction of the Scheme by... Source: Globe Newswire Nov 26, 2025 @ 2:00 PM Mural Oncology Announces Final Cash Consideration ... Source: Mural Oncology Plc Oct 24, 2025 @ 8:25 PM Mural Oncology Announces that Mural Shareholders A... Source: Globe Newswire Oct 17, 2025 @ 3:45 PM XOMA Royalty and LAVA Therapeutics Announce Amendm... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $.81 $.74 Diluted EPS $.75 $.7 Revenue $ 47.11M $ 9.35M $ Gross Profit $ $ $ Net Income / Loss $ 21.64M $ 14.05M $ 9.19M Operating Income / Loss $ 1.95M $ -1.33M $ Cost of Revenue $ $ $ Net Cash Flow $ -16.26M $ $ PE Ratio 40.17     Splits Oct 18, 2016:   1:20 Aug 18, 2010:   1:15